SCHEMBL8310559

SCHEMBL8310559

O=C1NC(=S)S/C1=C\c1ccnc2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 7/20 0.64
▸ PIK3CD O00329 1/20 0.56
▸ CSNK2A2 P19784 1/20 0.56
▸ PIK3CA P42336 1/20 0.56
▸ PIK3CG P48736 1/20 0.56
▸ CLK1 P49759 1/20 0.56
▸ CLK3 P49761 1/20 0.56
▸ CSNK2B P67870 1/20 0.56
▸ CSNK2A1 P68400 1/20 0.56
▸ DYRK1A Q13627 1/20 0.56
▸ HASPIN Q8TF76 1/20 0.56
▸ DYRK2 Q92630 1/20 0.56
▸ MYLK2 Q9H1R3 1/20 0.56
▸ CLK4 Q9HAZ1 1/20 0.56
▸ STK17A Q9UEE5 1/20 0.56
▸ DYRK1B Q9Y463 1/20 0.56
▸ NAT1 P18440 4/20 0.56
▸ GSK3B P49841 1/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ MAPT P10636 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8310560 1.00 PIM1 (0.64) PIM1PIK3CDCSNK2A2PIK3CAPIK3CG
SCHEMBL1250373 0.86 CISD1 (0.64) PIM1PIK3CDCSNK2A2PIK3CAPIK3CG
SCHEMBL8171866 0.86 PIM1 (0.46) PIM1PIK3CDCSNK2A2PIK3CAPIK3CG
SCHEMBL1250371 0.86 CISD1 (0.64) PIM1PIK3CDCSNK2A2PIK3CAPIK3CG
SCHEMBL8171863 0.86 PIM1 (0.46) PIM1PIK3CDCSNK2A2PIK3CAPIK3CG
SCHEMBL2065588 0.79 PTP4A3 (0.64) PIM1PIK3CDCSNK2A2PIK3CAPIK3CG
SCHEMBL15304598 0.78 NAT1 (0.70) PIM1NAT1GSK3BMEN1MAPT
SCHEMBL27858519 0.78 NAT1 (0.70) PIM1NAT1GSK3BMEN1MAPT
SCHEMBL12892054 0.78 NAT1 (0.72) PIM1CSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL1247507 0.78 PIM1 (1.00) PIM1NAT1GSK3BMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 — — EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 — — US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 — — US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 — — US disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 — — EP disclosed
Send feedback